Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
SIGA announced first international delivery of Oral TPOXX
On Jun. 1, 2020, SIGA Technologies announced its first international delivery of TPOXX (tecovirimat), with 2,500 courses delivered…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Non-Profit Research | Therapeutics | Vaccine
International community rallied to support open research and science to fight COVID-19
On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…
CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
Johnson & Johnson received positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen
On May 29, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
Gilead and Arcus Biosciences established 10-year partnership to co-develop and co-commercialize next-generation cancer immunotherapies
On May 27, 2020, Gilead Sciences and Arcus Biosciences announced that the companies had entered into a 10-year…
International gnomAD Consortium released first major studies of human genetic variation
On May 27, 2020, an analyses of the largest publicly available catalog of human genomic data revealed new…
Sanofi announced pricing of Regeneron stock offering
On May 26, 2020, Sanofi announced that it had agreed to sell 11.8 million shares of Regeneron common…
Todos Medical announced cross-distribution agreement with L1 Systems for ventilators and COVID testing
On May 26, 2020, Todos Medical announced it had entered into a cross-distribution agreement with L1 Systems, a…
Rice University COVID-19 research fund awarded final grants
On May 26, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had awarded…
Biotechnology | COVID-19 | Disease | Infectious Disease | Life Science News | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
CIRM board expanded efforts of COVID-19 program
On May 22, 2020, the California Institute for Regenerative Medicine (CIRM) board expanded efforts related to the $5…
AstraZeneca advanced response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
Study of BioAegis’ lead product, Gelsolin, key component of NIAID strategic plan for COVID-19 research
On May 21, 2020, BioAegis Therapeutics announced that the National Institute of Health Clinical Center began measuring patient…
ViralClear closed $10.8 million equity financing for development of COVID-19 broad-spectrum oral anti-viral candidate merimepodib
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
CHF Solutions publication highlighted use of ultrafiltration for fluid management in COVID-19 patients
On May 20, 2020, CHF Solutions announced a publication highlighting the use of ultrafiltration for fluid management of…
Airway Therapeutics and Celonic Group collaborated to produce AT-100 as promising new candidate for Coronavirus
On May 20, 2020, Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant…
CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | NIH | Therapeutics
Autism risk estimated at 3 to 5% for children whose parents have a sibling with autism
On May 18, 2020, the NIH reported that roughly 3 to 5% of children with an aunt or…
Long-acting injectable drug prevents HIV among men and transgender women
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
FDA cleared IND application to enable phase II trial of ViralClear’s merimepodib to treat adult patients with advanced COVID-19 to proceed
On May 18, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the U.S. Food and Drug Administration…
CIRM board approved clinical trials targeting COVID-19 and sickle cell disease
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
NIH began clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
On May 14, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a clinical trial…
ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2
On May 14, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19
On May 12, 2020, the National Research Council of Canada (NRC) and the University of Saskatchewan’s (USask) Vaccine…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
The Jackson Laboratory provided widescale COVID-19 testing in Connecticut
On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…
Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortality
On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…
Regeneron and Colorado Center for Personalized Medicine announced major new human genetics research collaboration
On May 11, 2020, Regeneron and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado…
Bellerophon Therapeutics submited investigational NDA to study INOpulse inhaled nitric oxide for treatment of COVID-19
On May 11, 2020, Bellerophon Therapeutics announced the FDA accepted its Investigational New Drug (IND) application, allowing the…